NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
CDK Global, Inc. (NASDAQ: CDK)’s sale to Brookfield Business Partners and its institutional partners for $54.87 per share in cash. If you are a CDK shareholder, click here to learn more about your rights and options.
Tufin Software Technologies Ltd. (NYSE: TUFN)’s sale to Turn/River Capital for $13.00 per share in cash. If you are a Tufin shareholder, click here to learn more about your rights and options.
SailPoint Technologies Holdings, Inc. (NYSE: SAIL)’s sale to Thoma Bravo for $65.25 per share in cash. If you are a SailPoint shareholder, click here to learn more about your rights and options.
Sierra Oncology, Inc. (NASDAQ: SRRA)’s sale to GlaxoSmithKline plc for $55.00 per share in cash. If you are a Sierra Oncology shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
